Finance

Beta
Lists
CINGW:NASDAQ
Cingulate Inc
$0.019
-20.42%
(-0.0049) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CINGW...
Open
$0.02
High
$0.03
Low
$0.02
Mkt. cap
60.54M
Avg. vol.
28.50K
Volume
64.70K
52-wk high
$0.18
52-wk low
$0.02
Beta
0.84
No. of employees
14
Open
$0.02
High
$0.03
Low
$0.02
Mkt. cap
60.54M
Avg. vol.
28.50K
Volume
64.70K
52-wk high
$0.18
52-wk low
$0.02
Beta
0.84
No. of employees
14
News stories
From sources across the web
About Cingulate Inc
CEO-
Employees14
Founded2012
HeadquartersKansas City, Kansas, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
2.70M
2.85M
2.00M
2.18M
Cost of revenue
2.70M
2.85M
2.00M
2.18M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.95M
3.15M
3.58M
5.74M
Operating expense
1.95M
3.15M
3.58M
5.74M
Total operating expenses
4.65M
6.00M
5.59M
7.92M
Operating income
-4.65M
-6.00M
-5.59M
-7.92M
Other non operating income
-
-772.17K
-133.99K
-852.03K
EBT including unusual items
-4.79M
-7.34M
-6.27M
-9.31M
EBT excluding unusual items
-4.79M
-7.34M
-6.27M
-9.31M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.79M
-7.34M
-6.27M
-9.31M
Net profit margin
-
-
-
-
Earnings per share
-1.09
-1.35
-0.84
-0.95
Interest and investment income
-
-
369.27K
-
Interest expense
-138.76K
-573.06K
-921.92K
-536.84K
Net interest expenses
-138.76K
-573.06K
-552.66K
-536.84K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.50M
-5.89M
-5.46M
-7.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more